Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Clinical trial NCT03371082 · COMPLETED
Trial details
- NCT number
- NCT03371082
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2019-08-19
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.